2m 2m 2m 2m 2m 2m 2m
Halozyme Therape (HALO)
NASDAQ
$108.34+$0.17 (+0.16%)
Price as of Aug 21, 2026 7:42 PM EDT- $12.3BMarket Cap
- 50.61%1-Year Change
- BiotechnologyIndustry
Halozyme Therape (HALO)
$108.34+$0.17 (+0.16%)
Earnings Score
Valuation | HALO | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | -0 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | HALO | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 17.62% | ||
12-Month Momentum | 12.89% | ||
3-Month Risk Adjusted Momentum | 136.12% | ||
12-Month Risk Adjusted Momentum | 42.88% |
True Yield
Valuation | HALO | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.42% | ||
Net Debt Paydown Yield | -0.03% |
Financial Health Score
Valuation | HALO | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |